Background: Proton pump inhibitors (PPIs) have been associated with adverse events and increased mortality in patients diagnosed with cirrhosis (1). PPIs are commonly prescribed to patients with cirrhosis who present to the hospital with gastrointestinal bleeds (2). However, guidelines do not suggest routine usage of PPI in patients with cirrhosis without gastroesophageal reflux disease (GERD) [...]

Background: Proton Pump Inhibitors are widely misused in both the outpatient and inpatient setting. Often, they are initiated and continued for reasons that do not follow best practice guidelines. Purpose: A Proton Pump Inhibitor Stewardship Committee was created to address this problem as part of a Quality Improvement project. The goal was to determine the [...]